Biotech news for Monday, May 18, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Sana Biotechnology ( SANA ) said on Friday it sold about 21.6M shares through its at-the-market facility with TD Securities, generating net proceeds of roughly $69M. The company said the financing, together with a previously announced unrelated $25M investment…
Dougal Waters With the market having a volatile few months, b elow is a list of 10 mega-cap stocks ranked by their lowest year-to-date performance. The list includes companies from various sectors, including Information Technology, Financials, and Healthcare,…
Silexion Therapeutics ( SLXN ) announced on Friday that it has signed an agreement for the immediate exercise of around 2M outstanding warrants at a reduced price of $0.50 per share. The deal is expected to raise around $1M in gross
NanoViricides ( NNVC ) on Friday announced it has entered into a securities purchase agreement with a single fundamental institutional investor for the purchase and sale of 1.33M common shares, together with accompanying warrants to purchase 1.33M common share…
Gilead Sciences ( GILD ) announced that it has priced senior unsecured notes totaling $3B in a public offering. This includes $500M of 4.250% senior notes maturing in 2028, $1B of 4.400% senior notes maturing in 2029, $1B of 4.600% senior notes maturing in 203…
Earnings Call Insights: REGENXBIO (RGNX) Q1 2026 Management View "Earlier this morning, we announced positive top line data from the pivotal trial of RGX-202, our potential best-in-class investigational gene therapy for Duchenne muscular dystrophy." (President…
Earnings Call Insights: Celcuity (CELC) Q1 2026 Management View CEO Brian Sullivan said, "We continue to make great progress as we prepare for the potential approval and commercial launch of gedatolisib in the third quarter," and added that, with positive VIKT…